EMA unable to approve AstraZeneca vaccine in January, - media

Source : 112 Ukraine

The company hasn't even applied officially yet, the EMA Deputy CEO says
08:04, 30 December 2020


The EMA (European Medicines Authority) will not be able to approve the vaccine against Covid-19 developed by AstraZeneca and Oxford University in January. Deputy CEO of the EMA Noel Wathion said so as quoted by Reuters.

"They haven't even applied", the official told Belgian newspaper Het Nieuwsblad in the interview published on Tuesday.

According to him, European regulators only received certain information about the vaccine, which is not enough to "warrant a conditional marketing licence". "We need additional data about the quality of the vaccine. And after that, the company has to formally apply", Wathion stated.

He added that under these circumstances, it is unlikely that the drug will be approved next month.

Related: Europe rushes to boost vaccine output to speed pandemic exit

Last week, AstraZeneca claimed that its vaccine against Covid-19 should be also effective against the new strain of coronavirus.

Currently, tests are being run to look into the influence of the new mutation of Covid-19. British health minister Matt Hancock said he had provided full data package on the vaccine for the consideration of British medical regulators.

Related: Belarus' Health Ministry announces beginning of vaccination process


Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more